Tetsuhiro Horie

678 total citations
37 papers, 459 citations indexed

About

Tetsuhiro Horie is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Tetsuhiro Horie has authored 37 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Physiology. Recurrent topics in Tetsuhiro Horie's work include Bone Metabolism and Diseases (9 papers), Drug Transport and Resistance Mechanisms (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Tetsuhiro Horie is often cited by papers focused on Bone Metabolism and Diseases (9 papers), Drug Transport and Resistance Mechanisms (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Tetsuhiro Horie collaborates with scholars based in Japan, United States and Canada. Tetsuhiro Horie's co-authors include Eiichi Hinoi, Kazuya Fukasawa, Takashi Iezaki, Gyujin Park, Kakeru Ozaki, Yuki Onishi, Katsuyuki Kaneda, Yukio Yoneda, Takeshi Takarada and Manami Hiraiwa and has published in prestigious journals such as Molecular and Cellular Biology, Development and Scientific Reports.

In The Last Decade

Tetsuhiro Horie

33 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuhiro Horie Japan 14 282 132 85 51 51 37 459
Rihua Zhang China 14 309 1.1× 66 0.5× 78 0.9× 22 0.4× 71 1.4× 24 501
Li Cai China 11 232 0.8× 107 0.8× 82 1.0× 15 0.3× 45 0.9× 21 483
Junli Ge China 12 202 0.7× 186 1.4× 49 0.6× 23 0.5× 34 0.7× 18 563
Gaofeng Zheng China 13 228 0.8× 226 1.7× 69 0.8× 31 0.6× 32 0.6× 52 568
Katharina John Germany 13 182 0.6× 99 0.8× 102 1.2× 29 0.6× 38 0.7× 20 533
Yiping Hu China 12 194 0.7× 57 0.4× 62 0.7× 64 1.3× 20 0.4× 28 450
Seung-Yon Lee South Korea 8 280 1.0× 93 0.7× 104 1.2× 12 0.2× 58 1.1× 13 468
Chunbing Zheng China 8 461 1.6× 271 2.1× 112 1.3× 34 0.7× 19 0.4× 13 579
Manoj Nepal South Korea 13 403 1.4× 114 0.9× 121 1.4× 31 0.6× 12 0.2× 25 535
Yufan Zheng China 13 312 1.1× 77 0.6× 133 1.6× 33 0.6× 34 0.7× 24 518

Countries citing papers authored by Tetsuhiro Horie

Since Specialization
Citations

This map shows the geographic impact of Tetsuhiro Horie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuhiro Horie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuhiro Horie more than expected).

Fields of papers citing papers by Tetsuhiro Horie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuhiro Horie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuhiro Horie. The network helps show where Tetsuhiro Horie may publish in the future.

Co-authorship network of co-authors of Tetsuhiro Horie

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuhiro Horie. A scholar is included among the top collaborators of Tetsuhiro Horie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuhiro Horie. Tetsuhiro Horie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horie, Tetsuhiro, et al.. (2025). Integrated Bioinformatic Analyses Reveal Thioredoxin as a Putative Marker of Cancer Stem Cells and Prognosis in Prostate Cancer. Cancer Informatics. 24. 2693946432–2693946432.
2.
3.
Horie, Tetsuhiro, Hiroaki Hirata, Yuka Nakamura, et al.. (2024). Multiomics analyses reveal adipose-derived stem cells inhibit the inflammatory response of M1-like macrophages through secreting lactate. Stem Cell Research & Therapy. 15(1). 485–485. 2 indexed citations
4.
5.
Yoshida, Tomoki, Megumi Yamamoto, Kazuya Fukasawa, et al.. (2024). CDK8 inhibitor KY-065 rescues skeletal abnormalities in achondroplasia model mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167626–167626.
6.
Fukasawa, Kazuya, Akane Suzuki, Tetsuhiro Horie, et al.. (2023). MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells. Cancer Research Communications. 3(1). 148–159. 8 indexed citations
7.
Fukasawa, Kazuya, et al.. (2023). Amelioration of Osteoarthritis Development by Daily Oral Supplementation of Royal Jelly. Biological and Pharmaceutical Bulletin. 46(2). 348–353. 2 indexed citations
8.
Hiraiwa, Manami, Kazuya Fukasawa, Takashi Iezaki, et al.. (2022). SMURF2 phosphorylation at Thr249 modifies glioma stemness and tumorigenicity by regulating TGF-β receptor stability. Communications Biology. 5(1). 22–22. 17 indexed citations
9.
Nishikawa, Miyu, Kaori Yasuda, Keisuke Abé, et al.. (2020). Generation of novel genetically modified rats to reveal the molecular mechanisms of vitamin D actions. Scientific Reports. 10(1). 5677–5677. 13 indexed citations
10.
Park, Gyujin, Kakeru Ozaki, Tetsuhiro Horie, et al.. (2020). Daily oral supplementation of Hochu-Ekki-To prevents osteoclastic activation and bone loss in ovariectomized mice. Journal of Pharmacological Sciences. 145(1). 1–5. 1 indexed citations
11.
Hiraiwa, Manami, Kakeru Ozaki, Takanori Yamada, et al.. (2019). mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis. Frontiers in Pharmacology. 10. 684–684. 32 indexed citations
12.
Iezaki, Takashi, Tetsuhiro Horie, Kazuya Fukasawa, et al.. (2018). Translational Control of Sox9 RNA by mTORC1 Contributes to Skeletogenesis. Stem Cell Reports. 11(1). 228–241. 24 indexed citations
13.
Horie, Tetsuhiro, Kazuya Fukasawa, Takashi Iezaki, et al.. (2017). Hypoxic Stress Upregulates the Expression of <b><i>Slc38a1</i></b> in Brown Adipocytes via Hypoxia-Inducible Factor-1α. Pharmacology. 101(1-2). 64–71. 6 indexed citations
14.
Onishi, Yuki, Gyujin Park, Takashi Iezaki, et al.. (2016). The transcriptional modulator Ifrd1 is a negative regulator of BMP-2-dependent osteoblastogenesis. Biochemical and Biophysical Research Communications. 482(2). 329–334. 2 indexed citations
15.
Iezaki, Takashi, Kakeru Ozaki, Kazuya Fukasawa, et al.. (2016). ATF3 deficiency in chondrocytes alleviates osteoarthritis development. The Journal of Pathology. 239(4). 426–437. 45 indexed citations
16.
Nishimura, Masuhiro, H. Yoshitsugu, Tsuyoshi Yokoi, et al.. (2005). Evaluation of mRNA expression of human drug-metabolizing enzymes and transporters in chimeric mouse with humanized liver. Xenobiotica. 35(9). 877–890. 53 indexed citations
17.
Sakai, Ryosei, Shin‐ichi Fujita, Tetsuhiro Horie, et al.. (2000). Activin increases bone mass and mechanical strength of lumbar vertebrae in aged ovariectomized rats. Bone. 27(1). 91–96. 30 indexed citations
18.
Kakiki, Motoharu, et al.. (1997). Stereoselective determination of a new antidepressant, E2011, and its diastereoisomer as a metabolite by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 694(1). 153–161. 1 indexed citations
19.
Tsunoda, Hajime, Kazuyo Muramoto, Satoshi Katayama, et al.. (1990). Effects of a novel PAF antagonist, E6123, on PAF-indnced biological responses. European Journal of Pharmacology. 183(2). 215–215. 1 indexed citations
20.
Tsunoda, Hajime, Kazuyo Muramoto, Satoshi Katayama, et al.. (1990). Effects of a Novel PAF Antagonist, E6123, on PAF-Induced Biological Responses. Birkhäuser Basel eBooks. 31. 251–254. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rihua Zhang Breakdown of academic impact, for papers by Li Cai Breakdown of academic impact, for papers by Junli Ge Breakdown of academic impact, for papers by Gaofeng Zheng Breakdown of academic impact, for papers by Katharina John Breakdown of academic impact, for papers by Yiping Hu Breakdown of academic impact, for papers by Seung-Yon Lee Breakdown of academic impact, for papers by Chunbing Zheng Breakdown of academic impact, for papers by Manoj Nepal Breakdown of academic impact, for papers by Yufan Zheng
Rankless by CCL
2026